Thus, targeting STEAP1 and SP-NK1R signaling pathways, along with addressing ferroptosis, may provide therapeutic benefits in mitigating sepsis-induced ALI by reducing ferroptosis and associated inflammation. This evidence concerns the gene TACR1 and Sepsis.